e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Systemic effects of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Presence of cardiovascular risk markers in OSAS
A. Borba, G. Naveso, C. Oliveira, E. Magro, C. Rocha, A. Mineiro, J. Cardoso (Lisbon, Portugal)
Source:
Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Session:
Systemic effects of obstructive sleep apnoea
Session type:
Thematic Poster Session
Number:
3499
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Borba, G. Naveso, C. Oliveira, E. Magro, C. Rocha, A. Mineiro, J. Cardoso (Lisbon, Portugal). Presence of cardiovascular risk markers in OSAS. Eur Respir J 2007; 30: Suppl. 51, 3499
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Metabolic effects of OSAS and cardiovascular risk
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007
OSA and cardiovascular risk in women
Source: 5th Sleep and Breathing Conference
Year: 2019
OSAS and the incidence of cardiovascular disorders
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Cardiovascular risk markers in patients with OSA. Effects of CPAP treatment
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
The relationship between some oxidative stress markers and metabolic cardiovascular risk factors in the blood of different stage obstructive sleep apnea persons
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001
Correlates and assessment of excess cardiovascular risk in bronchiectasis
Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017
Year: 2017
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007
Prevalence and risk factors of depression in patients with COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
The association between COPD and cardiovascular disorders
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017
Is OSA an important risk factor for metabolic dysregulation in obese COPD patients
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Early cardiovascular disease markers in "healthy" OSA patients are correlated with sympathetic activity
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Relationship between sleep apnea syndrome, plasma myeloperoxidase levels and cardiovascular risk
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept